The new formulation combines components widely sought after for their specific roles in dermatological health. Botulinum Peptide supports a refined skin appearance, while GHK-Cu provides conditioning benefits. Succinic Acid offers antioxidant properties alongside PDRN and Exosomes, both of which are utilized in advanced rejuvenation and recovery protocols. This release follows the international success of the HYALMASS AQUA EXOSOME line.
In section Releases
MAYPHARM Launches HYALMASS AQUATOX Skin Solution
Seoul-based aesthetic firm MAYPHARM is expanding its portfolio with the introduction of HYALMASS AQUATOX, a multi-active skin solution. The product integrates five high-interest ingredients—PDRN, Exosomes, Botulinum Peptide, GHK-Cu, and Succinic Acid—into a single formulation, marking a strategic shift toward multifunctional, ingredient-driven skincare to meet rising global demand.
As the aesthetic market becomes increasingly crowded with products mimicking popular ingredient profiles and branding, MAYPHARM is urging distributors and consumers to exercise caution. The company emphasizes the necessity of verifying authorized supply channels and official packaging to ensure product authenticity. By consolidating these five active ingredients into one, the firm aims to streamline professional aesthetic procedures while reinforcing its market position against unauthorized imitations.
Comments (0)
No comments yet. Be the first!